Azitra (AZTR) Return on Capital Employed (2023 - 2026)
Azitra (AZTR) posted Return on Capital Employed of 168.52% for Q1 2026, up 44.96% on a QoQ basis from 306.18% in Q4 2025, and up 3929.0% year-over-year from 4.18% in Q1 2025.
Azitra (AZTR) Return on Capital Employed (2023 - 2026) Analysis & Trends
Azitra's Return on Capital Employed history runs 4 years deep, the most recent figure standing at 168.52% for Q1 2026.
- Quarterly Return on Capital Employed rose 3929.0% year-over-year to 168.52% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 168.52% (up 3929.0% YoY) and the FY2025 annual result came in at 214.02%, up 1195.0% from the prior year.
- Return on Capital Employed was 168.52% for Q1 2026 at Azitra, up from 306.18% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 106.55% in Q3 2023 and bottomed at 481.22% in Q3 2025.
- A 4-year average of 238.64% and a median of 204.28% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2025 — Return on Capital Employed slumped 27944 bps — and 2026, when it soared 3929 bps.
- Azitra's Return on Capital Employed stood at 158.53% in 2023, then increased by 4 bps to 152.73% in 2024, then slumped by 100 bps to 306.18% in 2025, then surged by 45 bps to 168.52% in 2026.
- Business Quant data shows AZTR's Return on Capital Employed at 168.52% in Q1 2026, 306.18% in Q4 2025, and 481.22% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | -107.40% |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn | 10.46% |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn | 21.10% |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn | 10.19% |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | 20.34% |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - | -68.84% |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - | -168.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168.52% |
| Dec 31, 2025 | -306.18% |
| Sep 30, 2025 | -481.22% |
| Jun 30, 2025 | -325.75% |
| Mar 31, 2025 | -207.81% |
| Dec 31, 2024 | -152.73% |
| Sep 30, 2024 | -201.78% |
| Jun 30, 2024 | -311.67% |
| Mar 31, 2024 | -204.28% |
| Dec 31, 2023 | -158.53% |
| Sep 30, 2023 | -106.55% |